[go: up one dir, main page]

ES2130148T3 - Cis-2-oxa-5,8-diazabiciclo(4.3.0)nonanos en forma enantiomera pura, asi como procedimiento para su preparacion. - Google Patents

Cis-2-oxa-5,8-diazabiciclo(4.3.0)nonanos en forma enantiomera pura, asi como procedimiento para su preparacion.

Info

Publication number
ES2130148T3
ES2130148T3 ES92122079T ES92122079T ES2130148T3 ES 2130148 T3 ES2130148 T3 ES 2130148T3 ES 92122079 T ES92122079 T ES 92122079T ES 92122079 T ES92122079 T ES 92122079T ES 2130148 T3 ES2130148 T3 ES 2130148T3
Authority
ES
Spain
Prior art keywords
oxa
preparation
pure
nonanos
enantiomera
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92122079T
Other languages
English (en)
Inventor
Thomas Dr Schenke
Andreas Dr Krebs
Uwe Dr Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2130148T3 publication Critical patent/ES2130148T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION CONCIERNE A 2 4.3.0] R1 Y R2 TIENEN EL SIGNIFICADO DADO EN LA DESCRIPCION, Y EL PROCEDIMIENTO PARA SU OBTENCION.
ES92122079T 1992-01-10 1992-12-28 Cis-2-oxa-5,8-diazabiciclo(4.3.0)nonanos en forma enantiomera pura, asi como procedimiento para su preparacion. Expired - Lifetime ES2130148T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4200415A DE4200415A1 (de) 1992-01-10 1992-01-10 Enantiomerenreine 2-oxa-5,8-diazabicyclo(4.3.0)nonane sowie verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES2130148T3 true ES2130148T3 (es) 1999-07-01

Family

ID=6449289

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92122079T Expired - Lifetime ES2130148T3 (es) 1992-01-10 1992-12-28 Cis-2-oxa-5,8-diazabiciclo(4.3.0)nonanos en forma enantiomera pura, asi como procedimiento para su preparacion.

Country Status (9)

Country Link
US (2) US5436334A (es)
EP (1) EP0551653B1 (es)
JP (1) JPH07252258A (es)
AT (1) ATE177748T1 (es)
CA (1) CA2086915A1 (es)
DE (2) DE4200415A1 (es)
DK (1) DK0551653T3 (es)
ES (1) ES2130148T3 (es)
GR (1) GR3030042T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652239A1 (de) 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
US6423843B1 (en) 1998-06-17 2002-07-23 Daiichi Pharmaceutical Co., Ltd. Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both
WO2006109156A1 (en) 2005-04-15 2006-10-19 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US7692015B2 (en) * 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3403194A1 (de) * 1984-01-31 1985-08-01 Degussa Ag, 6000 Frankfurt Optisch aktive 3,4-bis-(diphenylphosphino)-pyrrolidine, diese als chirale liganden enthaltende rhodiumkomplexe und deren verwendung
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe

Also Published As

Publication number Publication date
DE4200415A1 (de) 1993-07-15
JPH07252258A (ja) 1995-10-03
DE59209656D1 (de) 1999-04-22
CA2086915A1 (en) 1993-07-11
EP0551653B1 (de) 1999-03-17
EP0551653A1 (de) 1993-07-21
US5532364A (en) 1996-07-02
DK0551653T3 (da) 1999-10-11
US5436334A (en) 1995-07-25
ATE177748T1 (de) 1999-04-15
GR3030042T3 (en) 1999-07-30

Similar Documents

Publication Publication Date Title
RO114325B1 (ro) Derivaţi de sulfonilaminopirimidină şi procedeu de obţinere a acestora
EP0103833A3 (en) Diazabicyclo(3.3.1)nonanes
HK1011987A1 (en) Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines
ES2086346T3 (es) Derivados de acido quinoloncarboxilico, procedimiento para su fabricacion asi como su uso como agentes antiviricos.
TW248559B (es)
IL98256A0 (en) Preparation of substituted piperidines
PT81810A (en) Process for preparing 6,7-disubstituted 1-cyclopropyl-1,4-di-hydro-oxo-1,8-naphtyridine-3-carboxylic acids
JPS6419066A (en) Dihydropyridineamides
ATE30719T1 (de) Imino-2-pyrrolidine, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
ES2130148T3 (es) Cis-2-oxa-5,8-diazabiciclo(4.3.0)nonanos en forma enantiomera pura, asi como procedimiento para su preparacion.
DE69403541D1 (de) Lacton-Verbindung und Verfahren zu ihrer Herstellung
EP0218970A3 (en) Chiral rhodium-diphosphine complexes for asymmetrical hydrogenation
AU1630288A (en) Substituted compounds, processes for their preparation and uses thereof
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
DE69404932D1 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
TW232011B (es)
EP1018546A4 (en) Microorganisms that produce 5-aminolevulinate and methods of producing 5-aminolevulinate using the same
DE69405507D1 (de) Zwischenprodukte zur Herstellung von Vitamin A und von Carotenoiden und Verfahren zu deren Herstellung
ES8703855A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinotriazina
ES2066413T3 (es) Procedimiento para la purificacion de n,n-dietilmandelamida.
ZA937179B (en) Tetrahydorindazolone pharmaceutical compositions

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551653

Country of ref document: ES